Genetic alterations in urothelial bladder carcinoma: an updated review (Q36393012)

13 August 2017

1 reference

title

Genetic alterations in urothelial bladder carcinoma: an updated review (English)

1 reference

13 August 2017

1 reference

Paulette Mhawech-Fauceglia

series ordinal

1

1 reference

13 August 2017

Richard T Cheney

series ordinal

2

1 reference

13 August 2017

Juerg Schwaller

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

106

1 reference

13 August 2017

6

1 reference

13 August 2017

1205-1216

1 reference

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

13 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Mutations of mitotic checkpoint genes in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Aurora kinases in spindle assembly and chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

HER-2 and TOP2A coamplification in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Inactivation of the FHIT gene favors bladder cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

DNA methylation and cancer therapy: new developments and expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

The clinical application of targeting cancer through histone acetylation and hypomethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

WNT signalling and haematopoiesis: a WNT-WNT situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

21 January 2018

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.21743

1 reference

7 January 2021

Contemporary management of stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Loss of p63 expression is associated with tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

DeltaNp63 induces beta-catenin nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Amplification/overexpression of a mitotic kinase gene in human bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Over-expression and amplification of the c-myc gene in human urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

What we could do now: molecular pathology of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Role of FHIT in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Loss of FHIT expression in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

DNA methylation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Mutation of the 9q34 gene TSC1 in sporadic bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Gene discovery in bladder cancer progression using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21743

7 January 2021

Identifiers

DOI

10.1002/CNCR.21743

1 reference

13 August 2017

1 reference